Moseley Investment Management Inc. Buys 51 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Moseley Investment Management Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,139 shares of the medical equipment provider’s stock after acquiring an additional 51 shares during the period. Moseley Investment Management Inc.’s holdings in Intuitive Surgical were worth $1,116,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ISRG. State Street Corp lifted its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC lifted its stake in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after buying an additional 143,440 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.8% during the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. grew its stake in Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after buying an additional 24,183 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $538.88 on Wednesday. The company has a 50-day moving average of $537.05 and a 200-day moving average of $496.50. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $556.23. The company has a market capitalization of $191.94 billion, a price-to-earnings ratio of 86.64, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on ISRG shares. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Truist Financial raised their target price on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. Leerink Partners lifted their price target on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $554.17.

Insider Buying and Selling

In other news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 in the last 90 days. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.